Suk-Tak Chan

Suk-Tak Chan

Auto-generated profile, based on publicly available information

Suk-Tak Chan

Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Neurophotonics
Verified
Journal Article
Open access
PDF file
JSJuliette J. Selb
Juliette J. Selb
DBDavid A. Boas
David A. Boas
SCSuk-Tak Chan
Suk-Tak Chan
KEKarleyton C. Evans
Karleyton C. Evans
EBErin Buckley
Erin Buckley
SCStefan A. Carp
Stefan A. Carp
Near-infrared spectroscopy (NIRS) and diffuse correlation spectroscopy (DCS) are two noninvasive diffuse optical technologies that provide information about microvascular cerebral hemodynamic processes. NIRS is sensitive to variations in absorption by oxy- and deoxy-hemoglobin of near-infrared light propagating diffusively in the head, providing a measure of cerebral blood volume (CBV) and oxygenation changes.1 2. 3. – 4 DCS uses a long coherence length source and measures the decorrelation time scale of the intensity fluctuations of the multiple-scattered light, which relates to the motion of moving scattering centers, mostly consisting of red blood cells.5 6. – 7 Unlike indocyanine green bolus tracking methods that require the injection of a contrast agent,8 9. – 10 DCS provides a noninvasive and fast measure of blood flow relative changes. It quantifies a blood flow index that has been shown to correlate with cerebral blood flow (CBF) as assessed by other modalities such as transcranial Doppler (TCD) ultrasonography,11 12. – 13 phase-encoded velocity mapping magnetic resonance imaging (MRI),14 and Xenon-enhanced computed tomography.15 NIRS, and more recently and sporadically DCS, has been applied to a broad range of functional imaging and monitoring studies, including developmental studies in infants and children,16 17. 18. – 19 cognitive and memory assessment in mental disorders,20 21. – 22 and monitoring of cerebrovascular health in brain injured patients.15,23 24. 25. – 26

7 December 2018 in Pain
Verified
Journal Article
Closed access
SMSamantha M. Meints
Samantha M. Meints
IMIshtiaq Mawla
Ishtiaq Mawla
VNVitaly Napadow
Vitaly Napadow
JKJian Kong
Jian Kong
JGJessica Gerber
Jessica Gerber
RERobert R. Edwards
Robert R. Edwards
Changes in central pain processing have been shown in patients with chronic low-back pain (cLBP). We used quantitative sensory testing methods to identify differences in pain sensitization between patients with cLBP (N = 167) and healthy controls (N = 33). Results indicated that, compared with healthy pain-free controls, cLBP patients showed increased sensitivity and greater painful aftersensations for mechanical pressure and pin-prick stimuli and lower tactile spatial acuity in the 2-point discrimination task (ps < 0.05). Then, we examined the role of pain catastrophizing as a mediator of the group differences in pain sensitization. We found that catastrophizing partially accounted for group differences in pressure required to produce moderate pain. Finally, we examined the relationship between pain sensitization, catastrophizing, and clinical pain among patients with cLBP. We found that catastrophizing and deep-tissue pressure pain were associated with greater pain intensity in the past month, week, and at the visit as well as low-back pain bothersomeness. Furthermore, deep-tissue pressure pain mediated the associations between catastrophizing and both pain in the past month and low-back pain severity. Taken together, these results indicate that not only do patients with cLBP demonstrate increased pain sensitization and decreased sensitivity to innocuous stimuli, but these changes are also linked with increased catastrophizing. Furthermore, both catastrophizing and sensitization are associated with increased clinical pain among cLBP patients.

5 May 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
XKXuejun Kong
Xuejun Kong
JLJun Liu
Jun Liu
Kevin LiuKevin Liu
Kevin Liu
MKMadelyn Koh
Madelyn Koh
HSHannah Sherman
Hannah Sherman
YSYiqing Song
Yiqing Song
Autism spectrum disorder (ASD) is a rapidly growing neurodevelopmental disorder. Both probiotics and oxytocin were reported to have therapeutic potential; however, the combination therapy has not yet been studied. We conducted a randomized, double-blinded, placebo-controlled, 2-stage pilot trial in 35 individuals with ASD aged 3–20 years (median = 10.30 years). Subjects were randomly assigned to receive daily Lactobacillus plantarum PS128 probiotic (6 × 1010 CFUs) or a placebo for 28 weeks; starting on week 16, both groups received oxytocin. The primary outcomes measure socio-behavioral severity using the Social Responsiveness Scale (SRS) and Aberrant Behavior Checklist (ABC). The secondary outcomes include measures of the Clinical Global Impression (CGI) scale, fecal microbiome, blood serum inflammatory markers, and oxytocin. All outcomes were compared between the two groups at baseline, 16 weeks, and 28 weeks into treatment. We observed improvements in ABC and SRS scores and significant improvements in CGI-improvement between those receiving probiotics and oxytocin combination therapy compared to those receiving placebo (p < 0.05). A significant number of favorable gut microbiome network hubs were also identified after combination therapy (p < 0.05). The favorable social cognition response of the combination regimen is highly correlated with the abundance of the Eubacterium hallii group. Our findings suggest synergic effects between probiotics PS128 and oxytocin in ASD patients, although further investigation is warranted.

17 October 2018 in Pain
Verified
Journal Article
Closed access
JLJeungchan Lee
Jeungchan Lee
IMIshtiaq Mawla
Ishtiaq Mawla
JKJieun Kim
Jieun Kim
MLMarco L. Loggia
Marco L. Loggia
AOAna Ortiz
Ana Ortiz
VNVitaly Napadow
Vitaly Napadow
Although self-report pain ratings are the gold standard in clinical pain assessment, they are inherently subjective in nature and significantly influenced by multidimensional contextual variables. Although objective biomarkers for pain could substantially aid pain diagnosis and development of novel therapies, reliable markers for clinical pain have been elusive. In this study, individualized physical maneuvers were used to exacerbate clinical pain in patients with chronic low back pain (N = 53), thereby experimentally producing lower and higher pain states. Multivariate machine-learning models were then built from brain imaging (resting-state blood-oxygenation-level-dependent and arterial spin labeling functional imaging) and autonomic activity (heart rate variability) features to predict within-patient clinical pain intensity states (ie, lower vs higher pain) and were then applied to predict between-patient clinical pain ratings with independent training and testing data sets. Within-patient classification between lower and higher clinical pain intensity states showed best performance (accuracy = 92.45%, area under the curve = 0.97) when all 3 multimodal parameters were combined. Between-patient prediction of clinical pain intensity using independent training and testing data sets also demonstrated significant prediction across pain ratings using the combined model (Pearson's r = 0.63). Classification of increased pain was weighted by elevated cerebral blood flow in the thalamus, and prefrontal and posterior cingulate cortices, and increased primary somatosensory connectivity to frontoinsular cortex. Our machine-learning approach introduces a model with putative biomarkers for clinical pain and multiple clinical applications alongside self-report, from pain assessment in noncommunicative patients to identification of objective pain endophenotypes that can be used in future longitudinal research aimed at discovery of new approaches to combat chronic pain.

1 September 2009 in Brain Research
Verified
Journal Article
Closed access
KHKathleen K.S. Hui
Kathleen K.S. Hui
OMOvidiu Marina
Ovidiu Marina
JCJoshua D. Claunch
Joshua D. Claunch
ENErika E. Nixon
Erika E. Nixon
JFJiliang Fang
Jiliang Fang
BRBruce R. Rosen
Bruce R. Rosen

4 March 2019 in Pain
Verified
Journal Article
Closed access
YTYiheng Tu
Yiheng Tu
MJMinyoung Jung
Minyoung Jung
RGRandy L. Gollub
Randy L. Gollub
VNVitaly Napadow
Vitaly Napadow
JGJessica Gerber
Jessica Gerber
JKJian Kong
Jian Kong
Accumulating evidence has shown that complicated brain systems are involved in the development and maintenance of chronic low back pain (cLBP), but the association between brain functional changes and clinical outcomes remains unclear. Here, we used resting-state functional magnetic resonance imaging (fMRI) and multivariate pattern analysis to identify abnormal functional connectivity (FC) between the default mode, sensorimotor, salience, and central executive brain networks in cLBP and tested whether abnormal FCs are related to pain and comorbid symptoms. Fifty cLBP patients and 44 matched healthy controls (HCs) underwent an fMRI scan, from which brain networks were identified by independent component analysis. Multivariate pattern analysis, graph theory approaches, and correlation analyses were applied to find abnormal FCs that were associated with clinical symptoms. Findings were validated on a second cohort of 30 cLBP patients and 30 matched HCs. Results showed that the medial prefrontal cortex/rostral anterior cingulate cortex had abnormal FCs with brain regions within the default mode network and with other brain networks in cLBP patients. These altered FCs were also correlated with pain duration, pain severity, and pain interference. Finally, we found that resting-state FC could discriminate cLBP patients from HCs with 91% accuracy in the first cohort and 78% accuracy in the validation cohort. Our findings suggest that the medial prefrontal cortex/rostral anterior cingulate cortex may be an important hub for linking the default mode network with the other 3 networks in cLBP patients. Elucidating the altered FCs and their association with clinical outcomes will enhance our understanding of the pathophysiology of cLBP and may facilitate the development of pain management approaches.